☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Multi-Year
BARDA Signs a Multi-Year Agreement with Regeneron for its REGN-EB3 for National Preparedness
July 30, 2020
AbCellera Signs an Exclusive Multi-Year Agreement with Eli Lilly to Develop Abs for up to Nine Targets
May 25, 2020
Takeda Signs a Multi-Year Research Collaboration with Evotec to Expedite Research Program Across its Core Therapeutic Areas
April 6, 2020
Mount Sinai Signs a Multi-Year Collaboration with Harbour BioMed to Develop Novel Biotherapies for Multiple Cancer Indications and...
March 6, 2020
Veracyte Signs a Multi-Year Agreement with AstraZeneca
January 9, 2020
Arena Signs a Multi-Year Agreement with Beacon Discovery to Develop Therapies for Immune and Inflammatory Diseases
January 3, 2020
Load more...
Back to Home
Modal title
×
Modal body text goes here.